Solara Active Pharma Sciences shareholding pattern

SOLARA

471.5

6.90 (-1.44%)
Last updated on 20 Feb, 2026 | 15:50 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Solara Active Pharma Sciences Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

42%

Mutual Fund

1.18%

Insurance

0%

Foreign Institutional Investors

11.98%

Domestic Institutional Investors

2.46%

Retail

42.37%

Others

0.01%

Total Promoters
MAR '25
37.94%
JUN '25
42.01%
SEP '25
42.01%
DEC '25
42%

Summary

For Year 2025-26, Solara Active Pharma Sciences reports the following shareholding: Total Promoters at 42%, Mutual Fund at 1.18%, Insurance at 0%, Foreign Institutional Investors at 11.98%, Domestic Institutional Investors at 2.46%, and Retail at 42.37%. This breakdown provides a quick snapshot of ownership distribution for Solara Active Pharma Sciences in 2025-26.

Solara Active Pharma Sciences FAQs

As of 02-2026, the promoter shareholding in Solara Active Pharma Sciences stands at 42% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Solara Active Pharma Sciences is 11.98% and 2.46% respectively.

The retail shareholding of the Solara Active Pharma Sciences is 42.37%.

Changes in shareholding patterns of Solara Active Pharma Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Solara Active Pharma Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost